EUVIMEDEUVIMED entdecken
Crossref

A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration

Ning Sheng, Fei Xing, Qing-Yi Zhang, Jie Tan, Rong Nie, Kai Huang, He-Xi Li, Yan-Lin Jiang, Bo Tan, Zhou Xiang, Hui-Qi Xie

Chemical Engineering Journal · 2024-01 · 480 · 147985

DOI: 10.1016/j.cej.2023.147985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2024-01. Verfasst von Ning Sheng und 10 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sheng, N., Xing, F., Zhang, Q., Tan, J., Nie, R., Huang, K., Li, H., Jiang, Y., Tan, B., Xiang, Z., & Xie, H. (2024). A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration. Chemical Engineering Journal, 480, 147985. https://doi.org/10.1016/j.cej.2023.147985

Vancouver

Sheng N, Xing F, Zhang Q, Tan J, Nie R, Huang K, et al. A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration. Chemical Engineering Journal. 2024;480:147985. doi:10.1016/j.cej.2023.147985

BibTeX
@article{Sheng2024,
  author = {Sheng, Ning and Xing, Fei and Zhang, Qing-Yi and Tan, Jie and Nie, Rong and Huang, Kai and Li, He-Xi and Jiang, Yan-Lin and Tan, Bo and Xiang, Zhou and Xie, Hui-Qi},
  title = {A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration},
  journal = {Chemical Engineering Journal},
  year = {2024},
  volume = {480},
  pages = {147985},
  doi = {10.1016/j.cej.2023.147985}
}
Kostenlos starten →